Does treatment effect or side-effects have any significance for the connection between financing and conclusions in randomized trials?;Har behandlingseffekt eller bivirkninger betydning for sammenhængen mellem finansiering og konklusioner i randomiserede forsøg?

Ugeskrift for Laeger

Volumn 166, Issue 18, 2004, Pages 1676-1678

  Als Nielsen, Bodil E ^a   Chen, Wendong ^a   Gluud, Christian N ^a   Gluud, Lise Lotte ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; PLACEBO;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHICS; FINANCIAL MANAGEMENT; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICS; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG THERAPY; ECONOMICS; EPIDEMIOLOGY; NON PROFIT ORGANIZATION; PUBLICATION; REGRESSION ANALYSIS; STANDARD; STATISTICAL MODEL; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG THERAPY; HUMANS; LOGISTIC MODELS; META-ANALYSIS; ORGANIZATIONS, NONPROFIT; PERIODICALS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RESEARCH SUPPORT; TREATMENT OUTCOME;

EID: 2542462059     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med 1986;1:155-8.
2. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in BMJ. BMJ 2002;325:249-52.
3. Djulbegovic B, Lacevic M, Cantor A et al. The uncertainty principle and industry-sponsored research. Lancet 2000;356:635-8.
4. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-65.
5. Lexchin J, Bero LA, Djulbegovic B et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
6. Gilbert JP, McPeek B, Mosteller F. Statistics and ethics in surgery and anesthesia. Science 1977;198:684-9.
7. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982-9.
8. Clifford T, Barrowman N, Moher D. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study. BMC Health Services Research 2002;2:18-23.
9. Gøtzsche PC, Liberati A, Torri V, et al. Beware of surrogate outcome measures. Int J Technol Assess Health Care 1996;12:238-46.
10. Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266:93-8.
11. Moher D, Schulz KF, Altman DG, et al. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. JAMA 2001;285:1987-91.
12. Davidoff F, DeAngelis CD, Drazen JM et al. Sponsorship, authorship, and accountability. JAMA 2001;286:1232-4.